YD Bio (YDES)
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treat...
- Open
- 4.560
- High
- 5.000
- Low
- 4.440
- Prev. Close
- 4.786
- Volume
- 26.55K
- Turnover
- 127.03K
- Avg Price
- 4.784
- Bid/Ask Ratio
- -99.10%
- Amplitude
- 11.70%
- 52wk High
- 25.000
- Volume Ratio
- 1.07
- Turnover Ratio
- 0.04%
News
- Price Alert · 22 hours ago
U.S. Stock Market Midday Update: YD Bio Soars 109% in 10 Days Without Any Good News? Speculative Trading May Carry Adjustment Risks
- Price Alert · Aug 18 at 12:13 PM
U.S. stock market midday update: YD Bio up 14.54% with no positive news? Capital influx shows volatility, reasons to be observed
- rttnews · Aug 17 at 09:13 PM
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day
- Price Alert · Aug 17 at 02:43 PM
U.S. Stock Market Midday Update: YD Bio Rises 31.9% in Five Days Without Positive News? Capital Inflows Drive Volatility
- PUBT · Aug 4 at 07:07 AM
YD Bio highlights peer-reviewed computational study nominating keratoconus regenerative therapy targets
- PUBT · Jul 28 at 07:01 AM
YD Bio launches cancer testing pilot with Numia Health in Canada
